D Reinhold

Summary

Affiliation: Otto-von-Guericke University
Country: Germany

Publications

  1. ncbi Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones
    D Reinhold
    Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto von Guericke University, Magdeburg, Germany
    J Neuroimmunol 87:203-9. 1998
  2. ncbi Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses
    Dirk Reinhold
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Ann N Y Acad Sci 1110:402-9. 2007
  3. ncbi The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth
    S Wrenger
    Center for Internal Medicine, Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, D 39120 Magdeburg, Germany
    J Biol Chem 272:30283-8. 1997
  4. ncbi Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation
    Dirk Reinhold
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Int Immunopharmacol 6:1935-42. 2006
  5. ncbi DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
    Dirk Reinhold
    Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Germany
    Front Biosci 13:2356-63. 2008
  6. ncbi CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells
    D Reinhold
    Department of Internal Medicine, Otto von Guericke University, Magdeburg
    Immunobiology 195:119-28. 1996
  7. ncbi The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells
    S Wrenger
    Center for Internal Medicine, Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Germany
    FEBS Lett 383:145-9. 1996
  8. ncbi Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1)
    M Arndt
    Institute of Immunology, Centre of Internal Medicine, Otto von Guericke University, Leipziger Strasse 44, Magdeburg, D 39120
    Biochem Biophys Res Commun 274:410-4. 2000
  9. ncbi Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes
    D Reinhold
    Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto von Guericke University Magdeburg, Germany
    FEBS Lett 428:100-4. 1998
  10. ncbi Expression of cathepsin K in lung epithelial cells
    F Buhling
    Institute of Immunology, Institute of Pathology, Department of Pneumology and Critical Care, Magdeburg, Germany
    Am J Respir Cell Mol Biol 20:612-9. 1999

Collaborators

Detail Information

Publications56

  1. ncbi Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones
    D Reinhold
    Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto von Guericke University, Magdeburg, Germany
    J Neuroimmunol 87:203-9. 1998
    ..Further in-vivo investigations, first in experimental models, will clarify, whether the inhibition of the enzymatic activity of DP IV could be a useful tool for therapeutic interventions in MS or other autoimmune diseases...
  2. ncbi Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses
    Dirk Reinhold
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Ann N Y Acad Sci 1110:402-9. 2007
    ..This review summarizes the evidence for the role of both enzymes in T cell activation in vitro and in vivo and provides a rationale for using combined and dual peptidase inhibitors to treat autoimmune diseases like MS...
  3. ncbi The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth
    S Wrenger
    Center for Internal Medicine, Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, D 39120 Magdeburg, Germany
    J Biol Chem 272:30283-8. 1997
    ..Our data suggest that the N-terminal residues of HIV-1 Tat do interact directly with the active site of DP IV and that DP IV does mediate Tat's immunosuppressive effects...
  4. ncbi Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation
    Dirk Reinhold
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Int Immunopharmacol 6:1935-42. 2006
    ....
  5. ncbi DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
    Dirk Reinhold
    Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Germany
    Front Biosci 13:2356-63. 2008
    ..In the following, we summarize the evidence for the role of both ectoenzymes in T cell activation in vitro and in vivo and provide a rationale for the use of combined or dual ectopeptidase inhibitors to treat autoimmune diseases like MS...
  6. ncbi CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells
    D Reinhold
    Department of Internal Medicine, Otto von Guericke University, Magdeburg
    Immunobiology 195:119-28. 1996
    ..1994, vol. 192, pp. 121-136). These data strongly suggest that Tat protein is a potent "natural" inhibitor of DP IV/CD26, and they support the hypothesis that DPIV plays a role in Tat's immunosuppressive activity...
  7. ncbi The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells
    S Wrenger
    Center for Internal Medicine, Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Germany
    FEBS Lett 383:145-9. 1996
    ..These data suggest the existence of endogenous immunomodulatory oligopeptides which influence immune cell proliferation and differentiation via DP IV as does HIV-1 Tat...
  8. ncbi Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1)
    M Arndt
    Institute of Immunology, Centre of Internal Medicine, Otto von Guericke University, Leipziger Strasse 44, Magdeburg, D 39120
    Biochem Biophys Res Commun 274:410-4. 2000
    ..The presented data fit into the hypothesis that inhibition of DP IV leads to the induction of TGF-beta(1), which in turn provokes an arrest of cell cycle in late G(1)...
  9. ncbi Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes
    D Reinhold
    Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto von Guericke University Magdeburg, Germany
    FEBS Lett 428:100-4. 1998
    ..These data demonstrate that CD26 plays a role also in regulation of DNA synthesis of epidermal keratinocytes and that the enzymatic activity is required for mediating these effects...
  10. ncbi Expression of cathepsin K in lung epithelial cells
    F Buhling
    Institute of Immunology, Institute of Pathology, Department of Pneumology and Critical Care, Magdeburg, Germany
    Am J Respir Cell Mol Biol 20:612-9. 1999
    ..These findings demonstrate that bronchial and alveolar epithelial cells are capable of expressing cathepsin K, which could be of considerable importance for remodeling processes of the extracellular matrix in the lung...
  11. ncbi Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor
    S Wrenger
    Institute of Experimental Internal Medicine, Department of Internal Medicine, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Biol Chem 275:22180-6. 2000
    ..These data suggest that the N-terminal part of TXA2-R is an endogenous inhibitory ligand of DP IV and may modulate T cell activation via DP IV/CD26 inhibition...
  12. ncbi Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease
    Ute Bank
    IMTM GmbH, Leipziger Str 44, 39120 Magdeburg, Germany
    Int Immunopharmacol 6:1925-34. 2006
    ..In summary our results strongly suggest that combined DPIV and APN inhibition by synthetic inhibitors represents a novel and efficient approach for the pharmacological therapy of IBD by triggering endogenous immunosuppressive mechanisms...
  13. ncbi Synergistic action of DPIV and APN in the regulation of T cell function
    Uwe Lendeckel
    Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    Adv Exp Med Biol 524:123-31. 2003
    ..Therefore, the simultaneous inhibition of these enzymes represents a promising strategy for the pharmacological therapy of T cell mediated diseases such as autoimmune disease, inflammation, allergy, and allograft rejection...
  14. ncbi Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia
    F Buhling
    Institute of Immunology, Otto von Guericke University Magdeburg, Germany
    J Interferon Cytokine Res 19:271-8. 1999
    ..42 nmol/L). Our results strongly suggest that different lung diseases do differ with regard to the released cytokines. TGF-beta1 probably plays a key role in regulation of pulmonary inflammation, particularly in pneumonia...
  15. ncbi Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation
    U Bank
    Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Germany
    J Interferon Cytokine Res 19:1277-87. 1999
    ..These results strongly suggest a pathophysiologic role of neutrophil-derived serine proteases, particularly in regulation of the expression of functional IL-2 and IL-6 receptors at foci of inflammation...
  16. ncbi CD26/dipeptidyl peptidase IV in lymphocyte growth regulation
    S Ansorge
    Department of Internal Medicine, Otto von Guericke University Magdeburg, Germany
    Adv Exp Med Biol 421:127-40. 1997
    ..e. substrates and effectors, which are play the central role in DP IV/CD26 action in T cell growth and to understand the molecular mechanism of the early steps of this fundamental process...
  17. ncbi Normal T-cell development and immune functions in TRIM-deficient mice
    Uwe Kölsch
    Institute of Immunology, Otto von Guericke University, Leipziger Str 44, 39120 Magdeburg, Germany
    Mol Cell Biol 26:3639-48. 2006
    ..The lack of an evident phenotype could indicate that TRIM shares redundant functions with other transmembrane adaptors involved in regulating the immune response...
  18. ncbi Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation
    U Bank
    Institute of Immunology, Center of Internal Medicine, Otto von Guericke University, Leipziger Strasse 44, D 39120, Magdeburg, Germany
    FEBS Lett 461:235-40. 1999
    ..The inactivation of IL-6 by neutrophil-derived serine proteases might act as a feedback mechanism terminating the IL-6-induced activation of neutrophils...
  19. ncbi Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice
    Dirk Reinhold
    Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Magdeburg, Germany
    Clin Chem Lab Med 47:268-74. 2009
    ....
  20. ncbi Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells
    D Reinhold
    Department of Internal Medicine, Otto-von-Guericke-University Magdeburg, Germany
    Horm Metab Res 28:267-70. 1996
    ..Our results indicate that high glucose-induced TGF-beta 1 production may suppress immune response by inhibiting the endogenous production of IL-2, IL-6 and IL-10...
  21. ncbi CD26/DP IV in T cell activation and autoimmunity
    Vera Preller
    Institute of Immunology Otto-von-Guericke University, Leipziger Str 44, D-39120 Magdeburg, Germany
    Adv Exp Med Biol 575:187-93. 2006
  22. ncbi The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases
    Anja Thielitz
    University Clinic of Dermatology and Venereology, Otto von Guericke University Magdeburg, Germany
    Front Biosci 13:2364-75. 2008
    ..Targeting enzyme activity of DP IV and APN and their related molecules might be a novel approach for the treatment of acne, psoriasis or keloids...
  23. ncbi Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells
    F Buhling
    Department of Internal Medicine, Medical Academy Magdeburg, Germany
    Nat Immun 13:270-9. 1994
    ..From these data we conclude that DP IV is involved in the regulation of proliferation of NK cells, whereas natural cytotoxicity seems to be regulated independently...
  24. ncbi MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia
    F Buhling
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Strasse 44, Magdeburg, Germany
    Immunol Lett 71:185-90. 2000
    ..The characterisation of subpopulations within the alveolar macrophages may be a useful tool for the monitoring of disease progression...
  25. ncbi Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases
    Ulrike C Kuhlmann
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Life Sci 84:1-11. 2009
    ..Here we investigated for the first time the effects of DP-IV-related protease inhibitors and APN inhibitors on chronic inflammatory lung diseases...
  26. ncbi Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function
    Sabine Wrenger
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    J Leukoc Biol 80:621-9. 2006
    ..In summary, here, we demonstrate for the first time expression of attractin on monocytes and provide first data suggesting that drugs directed to DP IV-like enzyme activity could affect monocyte function via attractin inhibition...
  27. ncbi Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma
    Thomas Schneider
    Department of Neurosurgery, Otto von Guericke University, Leipziger Strasse 44, D 39120, Magdeburg, Germany
    J Neurooncol 79:61-5. 2006
    ..lt;6 ng/ml clearly correlates with a longer survival time. In conclusion, this study suggests that glioblastoma does secret TGF-beta2 in vivo and that TGF-beta2 may play an important role in glioblastoma patients...
  28. ncbi Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation
    Anja Thielitz
    Department of Dermatology and Venereology, Otto von Guericke University Magdeburg, Magdeburg, Germany
    J Invest Dermatol 127:1042-51. 2007
    ....
  29. ncbi The transmembrane adapter protein SIT regulates thymic development and peripheral T-cell functions
    Luca Simeoni
    Otto von Guericke University, Institute of Immunology, Magdeburg, Germany
    Mol Cell Biol 25:7557-68. 2005
    ..These results demonstrate that SIT is a critical negative regulator of TCR-mediated signaling and finely tunes the signals required for thymic selection and peripheral T-cell activation...
  30. ncbi The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity
    Dirk Reinhold
    Institute of Immunology, Otto von Gueircke University Magdeburg, Germany
    Biol Chem 383:1133-8. 2002
    ..A major focus of this review are clinical aspects of the function of CD26 on hematopoietic cells and the potential usage of synthetic DP IV inhibitors as therapeutics in inflammatory disorders...
  31. ncbi Calpains and cytokines in fibrillating human atria
    Andreas Goette
    Division of Cardiology, Department of Internal Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany
    Am J Physiol Heart Circ Physiol 283:H264-72. 2002
    ..In conclusion, atria of patients with permanent AF show evidence of calpain I activation that might contribute to structural remodeling and contractile dysfunction, whereas there is no evidence of activation of tissue cytokines...
  32. ncbi Inhibition of human leukocyte function, alanyl aminopeptidase (APN, CD13) and dipeptidylpeptidase IV (DP IV, CD26) enzymatic activities by aqueous extracts of Cistus incanus L. ssp. incanus
    Uwe Lendeckel
    Institute of Experimental Internal Medicine, Center of Internal Medicine, Otto von Guericke University Magdeburg, Leipziger Str 44, D 39120 Magdeburg, Germany
    J Ethnopharmacol 79:221-7. 2002
    ..Data are presented suggesting that the antiproliferative effects of CIT extracts are due to their strong cytotoxic activity...
  33. ncbi Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation
    Anja Thielitz
    Department of Dermatology and Venereology, IMTM, Leipziger Str 44, 39120 Magdeburg, Germany
    Biochem Biophys Res Commun 321:795-801. 2004
    ..Taken together, these data suggest that targeting alanyl aminopeptidases may be beneficial for psoriasis and other inflammatory skin disorders...
  34. ncbi Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation
    Mandy Pierau
    Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Magdeburg, Germany
    J Immunol 183:6124-34. 2009
    ..Altogether, these data indicate an important role of PKB signals on control of TGF-beta1-mediated T cell responses and, thereby, on tolerizing and inflammatory immune processes...
  35. ncbi Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts
    Anja Thielitz
    University Clinic of Dermatology and Venereology, Otto von Guericke University, Magdeburg, Germany
    J Invest Dermatol 128:855-66. 2008
    ..Inhibition of DP IV-like enzymatic activity may therefore represent a promising therapeutic approach for the treatment of fibrotic skin disorders and keloids...
  36. ncbi Cathepsin K expression in human lung
    F Buhling
    Inst of Immunology, Otto von Guericke University Magdeburg, Germany
    Adv Exp Med Biol 477:281-6. 2000
    ..These data suggest that cathepsin K may play an important role in matrix remodeling of the lung under physiological and pathological conditions...
  37. ncbi Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions
    Siegfried Ansorge
    IMTM GmbH, Magdeburg, Germany
    Clin Chem Lab Med 47:253-61. 2009
    ..The first active dual inhibitor, IP10.C8, has been developed by IMTM for the treatment of inflammatory skin diseases and has just entered the first phase II study...
  38. ncbi Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
    Sabine Wrenger
    Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Germany
    Front Biosci 13:3194-201. 2008
    ..Further examinations are in progress to identify new physiologic, inhibitory DP IV ligands and to enlighten the mechanism underlying the DP IV-mediated effects...
  39. ncbi Expression of dipeptidyl peptidase IV-like enzymes in human peripheral blood mononuclear cells
    Sabine Wrenger
    Institute of Immunology, Otto-von-Guericke-University Magdeburg, Leipziger Strafle 44, 39120 Magdeburg, Germany
    Adv Exp Med Biol 575:87-91. 2006
  40. ncbi TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26
    Vera Preller
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany
    J Immunol 178:4632-40. 2007
    ..These results identify CD26/DP IV as a nonredundant inhibitory receptor controlling T cell activation and Th1-mediated autoimmunity, and may have important therapeutic implications for the treatment of autoimmune CNS disease...
  41. ncbi Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease
    D Roggenbuck
    Institute of Immunology, Technical University Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
    Gut 58:1620-8. 2009
    ..Autoimmune mechanisms are thought to play a role in the development of Crohn's disease, but the target antigens and the underlying pathways have not been sufficiently identified...
  42. ncbi Pro-inflammatory effector Th cells transmigrate through anti-inflammatory environments into the murine fetus
    J Wienecke
    Department of Experimental Paediatrics, University Hospital, Otto von Guericke University Magdeburg, Germany
    Placenta 33:39-46. 2012
    ..Our results suggest the possibility of novel roles for these maternal effector cells in the pathogenesis or reduction of disease...
  43. ncbi The imbalanced mixed lymphocyte reaction between maternal and fetal lymphocytes as well as between the lymphocytes of adult children and their parents is mediated by activated CD8+ T cells
    T Brune
    Department of Pediatrics, Otto von Guericke University, Magdeburg, Germany
    Am J Reprod Immunol 52:284-9. 2004
    ..The present investigation was aimed at examining which type of T cells has primary responsibility for this phenomenon...
  44. ncbi Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice
    Ute Bank
    IMTM GmbH, D 39120 Magdeburg, Germany
    Int J Mol Med 20:483-92. 2007
    ..We conclude that aminopeptidase inhibitors support the suppressive activity as well as TGF-beta1 and FoxP3 expression of natural regulatory T-cells...
  45. ncbi Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunoglobulins (i.v.IG) in patients with multiple sclerosis
    Dirk Reinhold
    Institute of Immunology, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Neuroimmunol 152:191-4. 2004
    ..v.IG therapy in MS. The variable amount of the potent anti-inflammatory TGF-beta isoforms within the i.v.IG preparations may exert a differentiated view regarding the manifold indications of i.v.IG therapy...
  46. ncbi Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
    Ute Bank
    IMTM GmbH, Department ImmunoPharm, Magdeburg, Germany
    Front Biosci 13:3699-713. 2008
    ....
  47. ncbi Radiation-induced matrix production of lung fibroblasts is regulated by interleukin-8
    Ulrike C Kuhlmann
    Institute of Clinical and Molecular Immunology, Otto von Guericke University Magdeburg, Magdeburg
    Int J Radiat Biol 85:138-43. 2009
    ..The factors that cause the actual fibrosis and the interaction between different cell types were investigated...
  48. ncbi Expression of SKAP-HOM in DCs is required for an optimal immune response in vivo
    Annegret Reinhold
    Institute of Molecular and Clinical Immunology, Otto von Guericke University, Magdeburg, Germany
    J Leukoc Biol 86:61-71. 2009
    ..Thus, these findings suggest that SKAP-HOM expression in DCs is required for the induction of an optimal immune response...
  49. ncbi Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis
    Ute Bank
    IMTM 2 tto-von-Guericke-University Magdeburg, L 39120 Magdeburg, Germany
    Adv Exp Med Biol 575:143-53. 2006
  50. ncbi Possible role of DP IV inhibitors in acne therapy
    Anja Thielitz
    Department of Dermatology and Venereology, Otto-von-Guericke University, Leipziger Str. 44, D-39120 Magdeburg, Germany
    Adv Exp Med Biol 575:163-7. 2006
  51. ncbi Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation
    Aliza Biton
    Department of Pathology, Faculty of Medicine, Hebrew University-Hadassah Medical School, POB 12272, 91120 Jerusalem, Israel
    Adv Exp Med Biol 575:177-86. 2006
  52. ncbi New results on the conformations of potent DP IV (CD26) inhibitors bearing the N-terminal MWP structural motif
    Carmen Mrestani-Klaus
    Department of Biochemistry/Biotechnology, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strsse 3, Halle, Germany
    Adv Exp Med Biol 524:65-8. 2003
  53. ncbi Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells
    Siegfried Ansorge
    Institute of Medical Technology Magdeburg, Germany
    Z Naturforsch C 58:580-9. 2003
    ..Thus, the bee product propolis can be considered as a powerful natural anti-inflammatory medicine influencing different types of immune-responses probably via immunoregulatory T cells...
  54. ncbi Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites
    Susan Lorey
    Department of Biochemistry Biotechnology, Institute of Biochemistry, Martin Luther University Halle Wittenberg, Halle, Germany
    Eur J Biochem 270:2147-56. 2003
    ..These findings give new insights for the development of more potent and specific peptide-based DP IV inhibitors. Such inhibitors could be useful for the treatment of autoimmune and inflammatory diseases...
  55. ncbi Deletion of the LIME adaptor protein minimally affects T and B cell development and function
    Claude Gregoire
    Centre d immunologie de Marseille Luminy, Universite de la Mediterranee, Marseille, France
    Eur J Immunol 37:3259-69. 2007
    ....